Sumitomo Pharma Co., Ltd. (4506.T)
JPY 941.0
(5.26%)
JPY 941.0
(5.26%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 187.98 Billion JPY | -50.09% |
| 2022 | 376.62 Billion JPY | -6.52% |
| 2021 | 402.9 Billion JPY | 6.54% |
| 2020 | 378.17 Billion JPY | 7.11% |
| 2019 | 353.05 Billion JPY | 2.12% |
| 2018 | 345.71 Billion JPY | -2.48% |
| 2017 | 354.49 Billion JPY | 13.78% |
| 2016 | 311.56 Billion JPY | 4.3% |
| 2015 | 298.73 Billion JPY | 10.58% |
| 2014 | 270.14 Billion JPY | -4.74% |
| 2013 | 283.59 Billion JPY | 15.26% |
| 2012 | 246.03 Billion JPY | -2.19% |
| 2011 | 251.53 Billion JPY | -6.66% |
| 2010 | 269.48 Billion JPY | 46.46% |
| 2009 | 183.99 Billion JPY | 14.79% |
| 2008 | 160.29 Billion JPY | -2.62% |
| 2007 | 164.6 Billion JPY | 1.69% |
| 2006 | 161.86 Billion JPY | 40.33% |
| 2005 | 115.34 Billion JPY | 80.26% |
| 2004 | 63.98 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 52.69 Billion JPY | -5.44% |
| 2024 Q1 | 55.72 Billion JPY | 20.77% |
| 2023 Q3 | 49.51 Billion JPY | 5.22% |
| 2023 Q2 | 47.06 Billion JPY | 3.99% |
| 2023 Q1 | 45.25 Billion JPY | -19.37% |
| 2023 Q4 | 46.14 Billion JPY | -6.82% |
| 2023 FY | 187.98 Billion JPY | -50.09% |
| 2022 Q2 | 112.62 Billion JPY | -1.05% |
| 2022 Q1 | 113.82 Billion JPY | 28.36% |
| 2022 Q4 | 56.12 Billion JPY | -40.32% |
| 2022 FY | 376.62 Billion JPY | -6.52% |
| 2022 Q3 | 94.05 Billion JPY | -16.49% |
| 2021 Q4 | 88.67 Billion JPY | -8.93% |
| 2021 FY | 402.9 Billion JPY | 6.54% |
| 2021 Q1 | 92.72 Billion JPY | 5.11% |
| 2021 Q2 | 124.15 Billion JPY | 33.9% |
| 2021 Q3 | 97.36 Billion JPY | -21.58% |
| 2020 FY | 378.17 Billion JPY | 7.11% |
| 2020 Q1 | 97.88 Billion JPY | 9.51% |
| 2020 Q2 | 92.91 Billion JPY | -5.08% |
| 2020 Q3 | 99.16 Billion JPY | 6.72% |
| 2020 Q4 | 88.21 Billion JPY | -11.04% |
| 2019 FY | 353.05 Billion JPY | 2.12% |
| 2019 Q1 | 88.53 Billion JPY | 5.36% |
| 2019 Q2 | 85.78 Billion JPY | -3.1% |
| 2019 Q3 | 89.35 Billion JPY | 4.16% |
| 2019 Q4 | 89.38 Billion JPY | 0.03% |
| 2018 Q1 | 86.99 Billion JPY | 4.14% |
| 2018 FY | 345.71 Billion JPY | -2.48% |
| 2018 Q2 | 83.56 Billion JPY | -3.95% |
| 2018 Q3 | 91.12 Billion JPY | 9.05% |
| 2018 Q4 | 84.02 Billion JPY | -7.8% |
| 2017 FY | 354.49 Billion JPY | 13.78% |
| 2017 Q4 | 83.54 Billion JPY | -9.57% |
| 2017 Q3 | 92.38 Billion JPY | 7.86% |
| 2017 Q2 | 85.65 Billion JPY | -1.3% |
| 2017 Q1 | 86.78 Billion JPY | 7.94% |
| 2016 Q3 | 80.95 Billion JPY | 14.6% |
| 2016 Q1 | 79.56 Billion JPY | 8.59% |
| 2016 Q4 | 80.4 Billion JPY | -0.69% |
| 2016 FY | 311.56 Billion JPY | 4.3% |
| 2016 Q2 | 70.64 Billion JPY | -11.21% |
| 2015 FY | 298.73 Billion JPY | 10.58% |
| 2015 Q4 | 73.27 Billion JPY | -6.81% |
| 2015 Q3 | 78.62 Billion JPY | 4.75% |
| 2015 Q2 | 75.06 Billion JPY | 4.58% |
| 2015 Q1 | 71.77 Billion JPY | 8.59% |
| 2014 Q2 | 64.15 Billion JPY | -2.29% |
| 2014 Q3 | 74.22 Billion JPY | 15.68% |
| 2014 Q4 | 66.09 Billion JPY | -10.94% |
| 2014 FY | 270.14 Billion JPY | -4.74% |
| 2014 Q1 | 65.66 Billion JPY | -14.93% |
| 2013 Q3 | 75.44 Billion JPY | 13.29% |
| 2013 FY | 283.59 Billion JPY | 15.26% |
| 2013 Q2 | 66.59 Billion JPY | 3.46% |
| 2013 Q1 | 64.36 Billion JPY | 21.04% |
| 2013 Q4 | 77.19 Billion JPY | 2.32% |
| 2012 Q1 | 63.87 Billion JPY | 5.9% |
| 2012 Q2 | 64.84 Billion JPY | 1.52% |
| 2012 Q3 | 64.14 Billion JPY | -1.07% |
| 2012 Q4 | 53.17 Billion JPY | -17.1% |
| 2012 FY | 246.03 Billion JPY | -2.19% |
| 2011 Q1 | 69.01 Billion JPY | -4.7% |
| 2011 Q3 | 62.97 Billion JPY | 6.29% |
| 2011 Q4 | 60.31 Billion JPY | -4.21% |
| 2011 FY | 251.53 Billion JPY | -6.66% |
| 2011 Q2 | 59.24 Billion JPY | -14.15% |
| 2010 Q4 | 72.41 Billion JPY | 9.2% |
| 2010 FY | 269.48 Billion JPY | 46.46% |
| 2010 Q2 | 61.56 Billion JPY | -11.0% |
| 2010 Q1 | 69.18 Billion JPY | 16.62% |
| 2010 Q3 | 66.31 Billion JPY | 7.71% |
| 2009 FY | 183.99 Billion JPY | 14.79% |
| 2009 Q4 | 59.32 Billion JPY | 35.48% |
| 2009 Q3 | 43.78 Billion JPY | 8.83% |
| 2009 Q2 | 40.23 Billion JPY | -1.02% |
| 2009 Q1 | 40.65 Billion JPY | 9.12% |
| 2008 Q2 | 39.18 Billion JPY | 0.0% |
| 2008 Q4 | 37.25 Billion JPY | -10.3% |
| 2008 Q3 | 41.53 Billion JPY | 6.0% |
| 2008 FY | 160.29 Billion JPY | -2.62% |
| 2007 FY | 164.6 Billion JPY | 1.69% |
| 2006 FY | 161.86 Billion JPY | 40.33% |
| 2005 FY | 115.34 Billion JPY | 80.26% |
| 2004 FY | 63.98 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 48.75 Billion JPY | -285.586% |
| Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 91.397% |
| Shionogi & Co., Ltd. | 369.08 Billion JPY | 49.069% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -5208.926% |
| Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | -93.761% |
| Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | -391.814% |
| Eisai Co., Ltd. | 586.41 Billion JPY | 67.944% |
| Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -3034.061% |
| Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | -138.038% |
| Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | -261.016% |
| Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | -1290.701% |
| Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | -2329.323% |
| Tsumura & Co. | 68.81 Billion JPY | -173.161% |
| Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | -403.417% |
| Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | -658.232% |
| Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | -130.983% |
| Fuji Pharma Co., Ltd. | 16.51 Billion JPY | -1038.244% |
| Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | -274.604% |
| KYORIN Holdings, Inc. | 51.4 Billion JPY | -265.722% |
| Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -17321.779% |
| Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | -1810.57% |
| SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -4161.628% |
| MedRx Co., Ltd | 26 Million JPY | -722903.846% |
| Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | -2242.233% |
| Solasia Pharma K.K. | 337 Million JPY | -55680.712% |
| Modalis Therapeutics Corporation | -731 Thousand JPY | 25715695.075% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | -513.015% |
| Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | -246.069% |
| Cyfuse Biomedical K.K. | 37.74 Million JPY | -497942.073% |
| Toho Holdings Co., Ltd. | 112.98 Billion JPY | -66.377% |
| Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | -2731.209% |